Korro Bio, Inc. KRRO
14.75 USD +0.02 (+0.14%)
At closeNov 6, 2026, 4:26 PM EST
14.75 0.00 0.00%
After hours · Nov 6, 4:26 PM ET
14.69 Day range 15.74
5.28 52-week range 33.84
- YTD
- +84.14%
- 1 year
- -54.71%
Analyst view
Consensus: buy
Buy
Price target (mean) 137.76 +833.9% upside
Now 14.75
- Target (low)
- 105.00
- Target (mean)
- 137.76
- Target (high)
- 180.00
Ratings (0m) 7 7 buy · 0 hold · 0 sell
- Strong buy4
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 6
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -2.60 | -2.90 – -2.32 | -43.10 | +94.0% | 0 | 0.0% | 6 |
| Next quarter | -2.69 | -3.12 – -2.39 | -2.44 | -10.2% | 0 | 0.0% | 5 |
| Current year | -9.22 | -9.80 – -7.59 | -53.08 | +82.6% | 0 | 0.0% | 6 |
| Next year | -9.73 | -11.60 – -8.31 | -9.22 | -5.6% | 0 | 0.0% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 18, 2024 | Jones Trading | Initiated | — | Buy |
| Nov 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 21, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 21, 2024 | Raymond James | Initiated | — | Strong Buy |
| Oct 18, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 19, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Sep 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 14, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 14, 2024 | William Blair | Initiated | — | Outperform |
| Aug 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 21, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 15, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 15, 2024 | BMO Capital | Maintained | Outperform | Outperform |
| Mar 28, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 27, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Mar 27, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Mar 26, 2024 | BMO Capital | Reiterated | Outperform | Outperform |
| Mar 12, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Feb 27, 2024 | BMO Capital | Initiated | — | Outperform |
| Jan 19, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 4, 2023 | HC Wainwright & Co. | Initiated | — | Buy |
| Nov 29, 2023 | RBC Capital | Initiated | — | Outperform |
| Nov 10, 2023 | Piper Sandler | Initiated | — | Overweight |